Drug General Information (ID: DDIAWEUYS4)
  Drug Name Valdecoxib Drug Info Meclofenamic acid Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antiinflammatory Agents Analgesics
  Structure

 Mechanism of Valdecoxib-Meclofenamic acid Interaction (Severity Level: Moderate)
     Increased risk of GI mucosal injury/bleeding risk Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Valdecoxib Meclofenamic acid
      Mechanism GI mucosal injury/bleeding risk GI mucosal injury/bleeding risk
      Key Mechanism Factor 1
Factor Name Gastrointestinal toxicity
Factor Description The risk and severity of gastrointestinal toxicity, including inflammation, bleeding, ulceration, and perforation, increases when drugs with gastrointestinal mucosal irritant effects are combined.
      Mechanism Description
  • Increased risk of GI mucosal injury/bleeding risk by the combination of Valdecoxib and Meclofenamic acid 

Recommended Action
      Management The use of COX-2 inhibitors with non-aspirin NSAIDs should be avoided. Some authorities consider the use of COX-2 inhibitors with non-aspirin NSAIDs as contraindicated.

References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3 Cerner Multum, Inc "ANVISA Bulario Eletrnico." .